ID   PPID_HUMAN              Reviewed;         370 AA.
AC   Q08752; B2R9V2;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 168.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase D;
DE            Short=PPIase D;
DE            EC=5.2.1.8 {ECO:0000269|PubMed:11350175};
DE   AltName: Full=40 kDa peptidyl-prolyl cis-trans isomerase;
DE   AltName: Full=Cyclophilin-40;
DE            Short=CYP-40;
DE   AltName: Full=Cyclophilin-related protein;
DE   AltName: Full=Rotamase D;
GN   Name=PPID; Synonyms=CYP40, CYPD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Pancreas;
RX   PubMed=8509368;
RA   Kieffer L.J., Seng T.W., Li W., Osterman D.G., Handschumacher R.E.,
RA   Bayney R.M.;
RT   "Cyclophilin-40, a protein with homology to the P59 component of the
RT   steroid receptor complex. Cloning of the cDNA and further
RT   characterization.";
RL   J. Biol. Chem. 268:12303-12310(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=8812478; DOI=10.1006/geno.1996.0384;
RA   Yokoi H., Shimizu Y., Anazawa H., Lefebvre C.A., Korneluk R.G.,
RA   Ikeda J.E.;
RT   "The structure and complete nucleotide sequence of the human
RT   cyclophilin 40 (PPID) gene.";
RL   Genomics 35:448-455(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-49; ILE-302 AND
RP   GLU-335.
RG   NIEHS SNPs program;
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-17.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH MYB.
RX   PubMed=9659917; DOI=10.1016/S1097-2765(00)80021-0;
RA   Leverson J.D., Ness S.A.;
RT   "Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative
RT   regulatory mechanism.";
RL   Mol. Cell 1:203-211(1998).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11525244; DOI=10.1379/1466-1268(2001)006<0059:HCIAHS>2.0.CO;2;
RA   Mark P.J., Ward B.K., Kumar P., Lahooti H., Minchin R.F.,
RA   Ratajczak T.;
RT   "Human cyclophilin 40 is a heat shock protein that exhibits altered
RT   intracellular localization following heat shock.";
RL   Cell Stress Chaperones 6:59-70(2001).
RN   [10]
RP   CATALYTIC ACTIVITY, FUNCTION, AND SUBUNIT.
RX   PubMed=11350175; DOI=10.1006/jmbi.2001.4595;
RA   Pirkl F., Buchner J.;
RT   "Functional analysis of the Hsp90-associated human peptidyl prolyl
RT   cis/trans isomerases FKBP51, FKBP52 and Cyp40.";
RL   J. Mol. Biol. 308:795-806(2001).
RN   [11]
RP   INTERACTION WITH HSP90AB1, AND MUTAGENESIS OF LYS-227; ASN-231;
RP   PHE-234; SER-274; ASN-278; LEU-284; LYS-285; LYS-308; ARG-312 AND
RP   ASP-329.
RX   PubMed=12145316; DOI=10.1074/jbc.M207097200;
RA   Ward B.K., Allan R.K., Mok D., Temple S.E., Taylor P., Dornan J.,
RA   Mark P.J., Shaw D.J., Kumar P., Walkinshaw M.D., Ratajczak T.;
RT   "A structure-based mutational analysis of cyclophilin 40 identifies
RT   key residues in the core tetratricopeptide repeat domain that mediate
RT   binding to Hsp90.";
RL   J. Biol. Chem. 277:40799-40809(2002).
RN   [12]
RP   IDENTIFICATION IN HSP90 COMPLEXES.
RX   PubMed=14580201; DOI=10.1021/bi035001t;
RA   Scroggins B.T., Prince T., Shao J., Uma S., Huang W., Guo Y.,
RA   Yun B.G., Hedman K., Matts R.L., Hartson S.D.;
RT   "High affinity binding of Hsp90 is triggered by multiple discrete
RT   segments of its kinase clients.";
RL   Biochemistry 42:12550-12561(2003).
RN   [13]
RP   INTERACTION WITH HSPA8, AND MUTAGENESIS OF LYS-227; ASN-231; PHE-234;
RP   SER-274; ASN-278; LEU-284; LYS-285; LYS-308 AND ARG-312.
RX   PubMed=15497503; DOI=10.1379/CSC-26R.1;
RA   Carrello A., Allan R.K., Morgan S.L., Owen B.A., Mok D., Ward B.K.,
RA   Minchin R.F., Toft D.O., Ratajczak T.;
RT   "Interaction of the Hsp90 cochaperone cyclophilin 40 with Hsc70.";
RL   Cell Stress Chaperones 9:167-181(2004).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18708059; DOI=10.1016/j.febslet.2008.08.007;
RA   Luu T.C., Bhattacharya P., Chan W.K.;
RT   "Cyclophilin-40 has a cellular role in the aryl hydrocarbon receptor
RT   signaling.";
RL   FEBS Lett. 582:3167-3173(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-198, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-198, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   FUNCTION.
RX   PubMed=19932913; DOI=10.1016/j.virol.2009.10.043;
RA   Gaither L.A., Borawski J., Anderson L.J., Balabanis K.A., Devay P.,
RA   Joberty G., Rau C., Schirle M., Bouwmeester T., Mickanin C., Zhao S.,
RA   Vickers C., Lee L., Deng G., Baryza J., Fujimoto R.A., Lin K.,
RA   Compton T., Wiedmann B.;
RT   "Multiple cyclophilins involved in different cellular pathways mediate
RT   HCV replication.";
RL   Virology 397:43-55(2010).
RN   [18]
RP   INTERACTION WITH ILF2; XRCC6; RACK1 AND RPS3.
RX   PubMed=21146485; DOI=10.1016/j.ab.2010.12.007;
RA   Park M.S., Chu F., Xie J., Wang Y., Bhattacharya P., Chan W.K.;
RT   "Identification of cyclophilin-40-interacting proteins reveals
RT   potential cellular function of cyclophilin-40.";
RL   Anal. Biochem. 410:257-265(2011).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   FUNCTION.
RX   PubMed=21711559; DOI=10.1186/1743-422X-8-329;
RA   Anderson L.J., Lin K., Compton T., Wiedmann B.;
RT   "Inhibition of cyclophilins alters lipid trafficking and blocks
RT   hepatitis C virus secretion.";
RL   Virol. J. 8:329-329(2011).
RN   [21]
RP   FUNCTION.
RX   PubMed=22681779; DOI=10.1186/1471-2407-12-229;
RA   Pearson J.D., Mohammed Z., Bacani J.T., Lai R., Ingham R.J.;
RT   "The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-
RT   positive, anaplastic large cell lymphoma viability and its expression
RT   is regulated by the NPM-ALK oncoprotein.";
RL   BMC Cancer 12:229-229(2012).
RN   [22]
RP   FUNCTION.
RX   PubMed=23220213; DOI=10.1016/j.yexcr.2012.11.016;
RA   Jandova J., Janda J., Sligh J.E.;
RT   "Cyclophilin 40 alters UVA-induced apoptosis and mitochondrial ROS
RT   generation in keratinocytes.";
RL   Exp. Cell Res. 319:750-760(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5 AND SER-198, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins. It catalyzes
CC       the cis-trans isomerization of proline imidic peptide bonds in
CC       oligopeptides. Proposed to act as a co-chaperone in HSP90
CC       complexes such as in unligated steroid receptors heterocomplexes.
CC       Different co-chaperones seem to compete for association with HSP90
CC       thus establishing distinct HSP90-co-chaperone-receptor complexes
CC       with the potential to exert tissue-specific receptor activity
CC       control. May have a preference for estrogen receptor complexes and
CC       is not found in glucocorticoid receptor complexes. May be involved
CC       in cytoplasmic dynein-dependent movement of the receptor from the
CC       cytoplasm to the nucleus. May regulate MYB by inhibiting its DNA-
CC       binding activity. Involved in regulation of AHR signaling by
CC       promoting the formation of the AHR:ARNT dimer; the function is
CC       independent of HSP90 but requires the chaperone activity. Involved
CC       in regulation of UV radiation-induced apoptosis. Promotes cell
CC       viability in anaplastic lymphoma kinase-positive anaplastic large-
CC       cell lymphoma (ALK+ ALCL) cell lines. May be involved in hepatitis
CC       C virus (HCV) replication and release.
CC       {ECO:0000269|PubMed:11350175, ECO:0000269|PubMed:18708059,
CC       ECO:0000269|PubMed:19932913, ECO:0000269|PubMed:21711559,
CC       ECO:0000269|PubMed:22681779, ECO:0000269|PubMed:23220213,
CC       ECO:0000269|PubMed:9659917}.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0). {ECO:0000269|PubMed:11350175}.
CC   -!- ENZYME REGULATION: Less sensitive to inhibition by cyclosporin A
CC       than is CYP-18.
CC   -!- SUBUNIT: Identified in ESR1 or NR3C1/GCR steroid receptor-
CC       chaperone complexes. Found in HSP90 chaperone complexes with
CC       kinase clients LCK or EIF2AK1. Two monomers associate with one
CC       HSP90 homodimer. Interacts with HSP90AA1. Interacts with HSP90AB1;
CC       PPID and FKBP4 compete for binding to HSP90AB1 and the interaction
CC       is mutually exclusive with the PPID:HSPA8 interaction. Interacts
CC       with HSPA8; PPID and STIP1 but not FKBP4 compete for binding to
CC       HSPA8 and the interaction is mutually exclusive with the
CC       PPID:HSP90AB1 interaction. Interacts with S100A1 and S100A2; the
CC       interactions dissociate the PPID:HSP90AA1 interaction. Interacts
CC       with S100A6. Interacts with MYB, ILF2, XRCC6, RACK1 and RPS3.
CC       Interacts with cytoplasmic dynein 1 intermediate chain (DYNC1I1 or
CC       DYNC1I2). {ECO:0000269|PubMed:11350175,
CC       ECO:0000269|PubMed:12145316, ECO:0000269|PubMed:14580201,
CC       ECO:0000269|PubMed:15497503, ECO:0000269|PubMed:21146485,
CC       ECO:0000269|PubMed:9659917}.
CC   -!- INTERACTION:
CC       Q12905:ILF2; NbExp=4; IntAct=EBI-716596, EBI-357925;
CC       P01103:MYB (xeno); NbExp=2; IntAct=EBI-716596, EBI-6502562;
CC       P63244:RACK1; NbExp=4; IntAct=EBI-716596, EBI-296739;
CC       P23396:RPS3; NbExp=4; IntAct=EBI-716596, EBI-351193;
CC       P12956:XRCC6; NbExp=4; IntAct=EBI-716596, EBI-353208;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11525244,
CC       ECO:0000269|PubMed:18708059}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:11525244, ECO:0000269|PubMed:18708059}.
CC       Nucleus, nucleoplasm {ECO:0000269|PubMed:11525244,
CC       ECO:0000269|PubMed:18708059}.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- SIMILARITY: Belongs to the cyclophilin-type PPIase family. PPIase
CC       D subfamily. {ECO:0000305}.
CC   -!- CAUTION: This protein should not be confused with mitochondrial
CC       peptidyl-prolyl cis-trans isomerase F (PPIF) which is often
CC       referred to as cyclophilin D or CypD. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ppid/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Cyclophilin entry;
CC       URL="https://en.wikipedia.org/wiki/Cyclophilin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L11667; AAA35731.1; -; mRNA.
DR   EMBL; D63861; BAA09923.1; -; Genomic_DNA.
DR   EMBL; AY714221; AAT97986.1; -; Genomic_DNA.
DR   EMBL; AK313929; BAG36649.1; -; mRNA.
DR   EMBL; CH471056; EAX04853.1; -; Genomic_DNA.
DR   EMBL; BC030707; AAH30707.1; -; mRNA.
DR   CCDS; CCDS3801.1; -.
DR   PIR; A45981; A45981.
DR   RefSeq; NP_005029.1; NM_005038.2.
DR   UniGene; Hs.183958; -.
DR   ProteinModelPortal; Q08752; -.
DR   SMR; Q08752; -.
DR   BioGrid; 111477; 55.
DR   DIP; DIP-34893N; -.
DR   IntAct; Q08752; 24.
DR   MINT; MINT-1399772; -.
DR   STRING; 9606.ENSP00000303754; -.
DR   BindingDB; Q08752; -.
DR   ChEMBL; CHEMBL1697657; -.
DR   iPTMnet; Q08752; -.
DR   PhosphoSitePlus; Q08752; -.
DR   BioMuta; PPID; -.
DR   DMDM; 729274; -.
DR   REPRODUCTION-2DPAGE; IPI00003927; -.
DR   EPD; Q08752; -.
DR   MaxQB; Q08752; -.
DR   PaxDb; Q08752; -.
DR   PeptideAtlas; Q08752; -.
DR   PRIDE; Q08752; -.
DR   DNASU; 5481; -.
DR   Ensembl; ENST00000307720; ENSP00000303754; ENSG00000171497.
DR   GeneID; 5481; -.
DR   KEGG; hsa:5481; -.
DR   UCSC; uc003iqc.4; human.
DR   CTD; 5481; -.
DR   DisGeNET; 5481; -.
DR   GeneCards; PPID; -.
DR   HGNC; HGNC:9257; PPID.
DR   HPA; HPA019520; -.
DR   HPA; HPA019692; -.
DR   MIM; 601753; gene.
DR   neXtProt; NX_Q08752; -.
DR   OpenTargets; ENSG00000171497; -.
DR   PharmGKB; PA33582; -.
DR   eggNOG; KOG0546; Eukaryota.
DR   eggNOG; COG0652; LUCA.
DR   GeneTree; ENSGT00550000074595; -.
DR   HOGENOM; HOG000065980; -.
DR   HOVERGEN; HBG053654; -.
DR   InParanoid; Q08752; -.
DR   KO; K05864; -.
DR   OMA; KGIGHTT; -.
DR   OrthoDB; EOG091G0BGL; -.
DR   PhylomeDB; Q08752; -.
DR   TreeFam; TF324493; -.
DR   BRENDA; 5.2.1.8; 2681.
DR   ChiTaRS; PPID; human.
DR   GeneWiki; PPID; -.
DR   GenomeRNAi; 5481; -.
DR   PRO; PR:Q08752; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000171497; -.
DR   CleanEx; HS_PPID; -.
DR   ExpressionAtlas; Q08752; baseline and differential.
DR   Genevisible; Q08752; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016018; F:cyclosporin A binding; TAS:UniProtKB.
DR   GO; GO:0030331; F:estrogen receptor binding; ISS:UniProtKB.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0030544; F:Hsp70 protein binding; ISS:UniProtKB.
DR   GO; GO:0051879; F:Hsp90 protein binding; IDA:UniProtKB.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0071492; P:cellular response to UV-A; IMP:UniProtKB.
DR   GO; GO:0061077; P:chaperone-mediated protein folding; IDA:UniProtKB.
DR   GO; GO:0034389; P:lipid particle organization; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0050714; P:positive regulation of protein secretion; IMP:UniProtKB.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB.
DR   GO; GO:0006461; P:protein complex assembly; IDA:UniProtKB.
DR   GO; GO:0006457; P:protein folding; ISS:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0019076; P:viral release from host cell; TAS:UniProtKB.
DR   Gene3D; 1.25.40.10; -; 1.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom.
DR   InterPro; IPR024936; Cyclophilin-type_PPIase.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom.
DR   InterPro; IPR019734; TPR_repeat.
DR   PANTHER; PTHR11071; PTHR11071; 1.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   Pfam; PF13176; TPR_7; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SMART; SM00028; TPR; 3.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
DR   PROSITE; PS50005; TPR; 3.
DR   PROSITE; PS50293; TPR_REGION; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Apoptosis; Chaperone; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Isomerase; Nucleus; Phosphoprotein;
KW   Polymorphism; Protein transport; Reference proteome; Repeat; Rotamase;
KW   TPR repeat; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:12665801}.
FT   CHAIN         2    370       Peptidyl-prolyl cis-trans isomerase D.
FT                                /FTId=PRO_0000064153.
FT   DOMAIN       19    183       PPIase cyclophilin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00156}.
FT   REPEAT      223    256       TPR 1.
FT   REPEAT      273    306       TPR 2.
FT   REPEAT      307    340       TPR 3.
FT   REGION      185    215       Chaperone activity. {ECO:0000250}.
FT   REGION      214    370       Interaction with HSP90AB1. {ECO:0000250}.
FT   MOD_RES       5      5       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     171    171       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9CR16}.
FT   MOD_RES     198    198       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT      49     49       R -> C (in dbSNP:rs2070631).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021021.
FT   VARIANT     196    196       D -> V (in dbSNP:rs2230222).
FT                                /FTId=VAR_051771.
FT   VARIANT     302    302       L -> I (in dbSNP:rs9410).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021022.
FT   VARIANT     335    335       G -> E (in dbSNP:rs17843956).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021023.
FT   MUTAGEN     227    227       K->A: Abolishes interaction with HSP90AB1
FT                                and impairs interaction with HSPA8.
FT                                {ECO:0000269|PubMed:12145316,
FT                                ECO:0000269|PubMed:15497503}.
FT   MUTAGEN     231    231       N->A: Abolishes interaction with HSP90AB1
FT                                and impairs interaction with HSPA8.
FT                                {ECO:0000269|PubMed:12145316,
FT                                ECO:0000269|PubMed:15497503}.
FT   MUTAGEN     234    234       F->A: Impairs interaction with HSP90AB1
FT                                and HSPA8. {ECO:0000269|PubMed:12145316,
FT                                ECO:0000269|PubMed:15497503}.
FT   MUTAGEN     274    274       S->L: Impairs interaction with HSP90AB1
FT                                and HSPA8. {ECO:0000269|PubMed:12145316,
FT                                ECO:0000269|PubMed:15497503}.
FT   MUTAGEN     278    278       N->A: Abolishes interaction with
FT                                HSP90AB1. {ECO:0000269|PubMed:12145316,
FT                                ECO:0000269|PubMed:15497503}.
FT   MUTAGEN     284    284       L->A: Impairs interaction with HSP90AB1
FT                                and HSPA8. {ECO:0000269|PubMed:12145316,
FT                                ECO:0000269|PubMed:15497503}.
FT   MUTAGEN     285    285       K->A: Impairs interaction with HSP90AB1
FT                                and HSPA8. {ECO:0000269|PubMed:12145316,
FT                                ECO:0000269|PubMed:15497503}.
FT   MUTAGEN     308    308       K->A: Abolishes interaction with HSP90AB1
FT                                and impairs interaction with HSPA8.
FT                                {ECO:0000269|PubMed:12145316,
FT                                ECO:0000269|PubMed:15497503}.
FT   MUTAGEN     312    312       R->A: Abolishes interaction with HSP90AB1
FT                                and impairs interaction with HSPA8.
FT                                {ECO:0000269|PubMed:12145316,
FT                                ECO:0000269|PubMed:15497503}.
FT   MUTAGEN     329    329       D->A: Impairs interaction with HSP90AB1.
FT                                {ECO:0000269|PubMed:12145316}.
SQ   SEQUENCE   370 AA;  40764 MW;  39D4100748B35D48 CRC64;
     MSHPSPQAKP SNPSNPRVFF DVDIGGERVG RIVLELFADI VPKTAENFRA LCTGEKGIGH
     TTGKPLHFKG CPFHRIIKKF MIQGGDFSNQ NGTGGESIYG EKFEDENFHY KHDREGLLSM
     ANAGRNTNGS QFFITTVPTP HLDGKHVVFG QVIKGIGVAR ILENVEVKGE KPAKLCVIAE
     CGELKEGDDG GIFPKDGSGD SHPDFPEDAD IDLKDVDKIL LITEDLKNIG NTFFKSQNWE
     MAIKKYAEVL RYVDSSKAVI ETADRAKLQP IALSCVLNIG ACKLKMSNWQ GAIDSCLEAL
     ELDPSNTKAL YRRAQGWQGL KEYDQALADL KKAQGIAPED KAIQAELLKV KQKIKAQKDK
     EKAVYAKMFA
//
